|
Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)
|
November 23, 2023
|
PC3I Authors Melina Marmarelis |
Lung Cancer
|
|
The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC
|
February 16, 2024
|
PC3I Authors Melina Marmarelis |
JTO Clinical and Research Reports
|
|
iNUDGE: Integration of liquid biopsy based next generation gene sequencing in newly diagnosed NSCLC—A stepped wedge cluster randomized clinical trial.
|
May 29, 2024
|
PC3I Authors Anthony Martella; Dylan G. Scholes; Meagan Hume; Charu Aggarwal; Christopher A. D’Avella; Ramy Sedhom; Peter Gabriel; Katharine Rendle; Justin Bekelman; Leland Boisseau; Melina Marmarelis |
Journal of Clinical Oncology
|
|
Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial
|
July 3, 2024
|
PC3I Authors Melina Marmarelis; Dylan G. Scholes; Peter Gabriel; Anthony Martella; David Dougherty; Larry Shulman; Justin Bekelman; Charu Aggarwal |
JCO Oncology Practice
|
|
Brief Report: Impact of Reflex Testing on Tissue-Based Molecular Genotyping in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
|
April 6, 2024
|
PC3I Authors Melina Marmarelis; Dylan G. Scholes; Peter Gabriel; Charu Aggarwal |
Clinical Lung Cancer
|
|
Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic
|
October 12, 2021
|
PC3I Authors Charu Aggarwal; Peter Gabriel; Larry Shulman; Melina Marmarelis |
BMC Cancer
|
|
Platinum Re-Exposure as a Non-Small Cell Lung Cancer (NSCLC) Treatment Strategy in the Age of Immunotherapy
|
January 30, 2022
|
PC3I Authors Melina Marmarelis; Ronac Mamtani; Charu Aggarwal |
Clinical Lung Cancer
|
|
A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry
|
February 5, 2022
|
PC3I Authors Melina Marmarelis |
Journal of Thoracic Oncology
|
|
Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC-Results From a Prospective Pilot Study
|
April 8, 2022
|
PC3I Authors Charu Aggarwal; Melina Marmarelis; Christopher A. D’Avella; Anil Vachani |
JTO Clinical and Research Reports
|
|
Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and Pemetrexed
|
April 8, 2022
|
PC3I Authors Charu Aggarwal; Melina Marmarelis; Christopher A. D’Avella |
Clinical Lung Cancer
|
|
Very high PD-L1 expression as a prognostic indicator of overall survival among patients with advanced non-small cell lung cancer receiving anti-PD-(L)1 monotherapies in routine practice
|
June 7, 2022
|
PC3I Authors Ronac Mamtani; Melina Marmarelis |
Pharmacoepidemiology and Drug Safety
|
|
Association Between Survival and Very High Versus High PD-L1 Expression in Patients Receiving Pembrolizumab as First-line Treatment for Advanced Non-Small Cell Lung Cancer
|
August 9, 2022
|
PC3I Authors Melina Marmarelis; Ronac Mamtani |
Clinical Lung Cancer
|
|
A single-center retrospective cohort study of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma
|
September 29, 2022
|
PC3I Authors Melina Marmarelis |
PLoS One
|
|
A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non-Small Cell Lung Cancer
|
February 25, 2023
|
PC3I Authors Melina Marmarelis |
Clinical Lung Cancer
|
|
Adjuvant Atezolizumab Should Be Administered to All Patients With Programmed Death-Ligand 1 Expressing Surgically Resected Stage II to III NSCLC After Chemotherapy: In Favor
|
February 26, 2023
|
PC3I Authors Melina Marmarelis; Charu Aggarwal |
Journal of Thoracic Oncology
|
|
Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma
|
March 10, 2023
|
PC3I Authors Melina Marmarelis |
JAMA Network Open
|
|
Chemoimmunotherapy vs. Immunotherapy for First Line Treatment of Advanced Non-small Cell Lung Cancer With a PD-L1 Expression ≥50% or ≥90
|
March 19, 2023
|
PC3I Authors Ronac Mamtani; Melina Marmarelis |
Clinical Lung Cancer
|
|
Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database
|
April 16, 2023
|
PC3I Authors Melina Marmarelis |
Cancer Medicine
|
|
Utilization and Factors Precluding Receipt of Checkpoint Inhibitor Consolidation for Stage III NSCLC in a Large US Academic Health System
|
April 19, 2023
|
PC3I Authors Michelle Iocolano; Christopher A. D’Avella; Melina Marmarelis; Charu Aggarwal |
Clinical Lung Cancer
|
|
Re-Evaluating Real-World Evidence in RET Fusion-Positive NSCLC: Are Randomized Clinical Trials Needed?
|
April 22, 2023
|
PC3I Authors Charu Aggarwal; Melina Marmarelis |
Journal of Thoracic Oncology
|
